Remedent, Inc.
REMI
$0.05
$0.000.00%
| 03/31/2021 | 12/31/2020 | 09/30/2020 | 06/30/2020 | 03/31/2020 | |
|---|---|---|---|---|---|
| Revenue | -554.00K | 337.50K | 321.90K | 219.10K | -573.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -554.00K | 337.50K | 321.90K | 219.10K | -573.90K |
| Cost of Revenue | -144.40K | 128.40K | 113.10K | 66.50K | -146.10K |
| Gross Profit | -409.60K | 209.00K | 208.90K | 152.60K | -427.90K |
| SG&A Expenses | 45.30K | 186.00K | 138.70K | 131.40K | -191.20K |
| Depreciation & Amortization | 6.20K | 8.70K | 8.90K | 10.70K | 9.50K |
| Other Operating Expenses | -378.90K | -- | -- | -- | -459.50K |
| Total Operating Expenses | -471.70K | 323.10K | 260.60K | 208.60K | -787.30K |
| Operating Income | -82.20K | 14.40K | 61.30K | 10.50K | 213.40K |
| Income Before Tax | -102.10K | 100.80K | 2.20K | 7.30K | 411.80K |
| Income Tax Expenses | -2.10K | 2.40K | -- | -- | -1.00K |
| Earnings from Continuing Operations | -100.00K | 98.40K | 2.20K | 7.30K | 412.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 8.50K | -3.90K | 1.80K | -6.10K | 900.00 |
| Net Income | -91.50K | 94.50K | 4.00K | 1.10K | 413.80K |
| EBIT | -82.20K | 14.40K | 61.30K | 10.50K | 213.40K |
| EBITDA | -73.30K | 23.10K | 70.20K | 21.20K | 226.40K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 |
| Normalized Basic EPS | -- | 0.00 | 0.00 | 0.00 | -- |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 |
| Normalized Diluted EPS | -- | 0.00 | 0.00 | 0.00 | -- |
| Average Basic Shares Outstanding | -- | 20.00M | 20.00M | 20.00M | -- |
| Average Diluted Shares Outstanding | 20.00M | 20.00M | 20.00M | 20.00M | 20.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
